Johnson & Johnson set to begin India trial of its single-shot vaccine, says report

Johnson & Johnson has told Indian regulators that it will soon begin clinical trials of its single-shot COVID-19 vaccine in the country, the Indian Express newspaper reported on Friday.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2Rh7ZwV
via IFTTT